Bowel Cancer and Biomarker Research Lab
Bowel cancer, also known as colorectal cancer, is the second most common cancer in Australian men and women. It affects 1 in 13 people. It is also Australia’s second deadliest cancer, with over 5,000 people dying each year. Early detection through screening can improve survival rates, however further research is needed to help find cures and prevent the disease.
The Bowel Cancer and Biomarker Laboratory at the Kolling Institute uses advanced technologies to study the genes and proteins responsible for bowel cancers growing and spreading. Our aim is to use a patient’s own molecular information to understand the risk of bowel cancer developing and to guide treatment options. As part of our research, we are studying how to control bowel polyp growth, which are precursors to cancer. We are doing this through diet and chemotherapy drugs.
Prof Mark P. Molloy, PhD | Lawrence Penn Chair of Bowel Cancer Research
The University of Sydney | Northern Clinical School
Faculty of Medicine and Health
Honorary Professor | Dept. Molecular Sciences, Macquarie University
Secretary | Australasian Proteomics Society
Dr Jun Li PhD
Postdoctoral Research Fellow
Dr Benita Tse
Postdoctoral Scientist
Matthew McKay - Senior Research Officer
Bharat Venkatesh Gunappa - Research Officer
Atul Bhatnagar - Senior Technical Officer
(Vo Van) Anh Pham - Honours Student
Miguel Castaneda - Research Assistant
Current bowel cancer research focuses on:
- Why and how some bowel polyps become cancers
- Which bowel tumours are likely to spread
- Molecular make-up of colorectal tumours
- Early detection of disease recurrence
Our research is facilitated by specimens from clinical projects we run including:
- Sydney 1000 bowel cancer study
- IMAP Bowel polyp study
Bowel Cancer and Biomarker Research related information
Events, News and Seminars
New approach revolutionising ovarian cancer research
Posted on: 13 March, 2023
With ovarian cancer continuing to have a devastating outcome for many women, new research at the Kol..... Read more
Category: New Treatment, Research Excellence
Recognition of our impact on the world stage
Posted on: 27 February, 2023
Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than ..... Read more
Category: Research Excellence
Philanthropic funds creating travel opportunities
Posted on: 20 February, 2023
A collection of emerging research leaders will have the chance to broaden their research experience ..... Read more
Category: Awards, Research Excellence